Wuesthoff & Wuesthoff competitive analysis

Explore patent oppositions filed by Wuesthoff & Wuesthoff against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Methods For Treating Cancer With Anti-Pd-1 AntibodiesMERCK SHARP & DOHMEAug 17, 2026
Xylylene Diisocyanate Composition, Polymerizable Composition For Optical Materials, Resin, Molded Body, Optical Element And LensMITSUI CHEMICALSAug 17, 2026
Kitchen Appliance System And Method For Operating SameVORWERK & INTERHOLDINGAug 4, 2026
Platforms For Mitral Valve ReplacementMAJORO CARDIAC INNOVATIONSJun 24, 2026
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 16, 2026
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofF HOFFMANN LA ROCHEJun 9, 2026
High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use ThereofEISAI R&D MANAGEMENTApr 1, 2026
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBMar 12, 2026
Cassette Design And Systems And Methods ThereofJOHNSON & JOHNSON SURGICAL VISIONFeb 5, 2026
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 16, 2025

Latest PTAB cases involving Wuesthoff & Wuesthoff

Discover the latest PTAB cases involving Wuesthoff & Wuesthoff, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Wuesthoff & Wuesthoff with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB35 - - -
CELGENE - 72 - 11
NOVARTIS6468 - 21
REGENERON PHARMACEUTICALS39141932